Greater Glasgow and Clyde Medicines

Latest Medicines Updates & News

Formulary Update (Feb 2017)

Posted: Monday, February 27, 2017

Category - Formulary Update

This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.

For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary.

Read More...

Formulary Update (Dec 2016)

Posted: Monday, December 19, 2016

Category - Formulary Update

This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines considered by the Area Drug and Therapeutics Committee (ADTC).  The new format, which is aimed at the public and patients is currently being piloted.

For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary.

Read More...

Formulary Update (Oct 2016)

Posted: Monday, October 17, 2016

Category - Formulary Update

This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines considered by the Area Drug and Therapeutics Committee (ADTC).  The new format, which is aimed at the public and patients is currently being piloted.

For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary.

Read More...

Formulary Update (August 2016)

Posted: Monday, August 29, 2016

Category - Formulary Update

This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines considered by the Area Drug and Therapeutics Committee (ADTC).  The new format, which is aimed at the public and patients is currently being piloted.

For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary.

Read More...

Formulary Update (June 2016)

Posted: Monday, June 20, 2016

Category - Formulary Update

This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines considered by the Area Drug and Therapeutics Committee (ADTC).  The new format, which is aimed at the public and patients is currently being piloted.

For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary.

Read More...

Formulary Update (April 2016)

Posted: Monday, April 25, 2016

Category - Formulary Update

This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines considered by the Area Drug and Therapeutics Committee (ADTC).  The new format, which is aimed at the public and patients is currently being piloted.

For full details of the medicines included in this post that are available for use, please see the relevant entry in the GGC Formulary.

Read More...

Formulary Update (February 2016)

Posted: Monday, February 29, 2016

Category - Formulary Update

This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines considered by the Area Drug and Therapeutics Committee (ADTC).  The new format, which is aimed at the public and patients is currently being piloted.

For full details of the medicines included in this post that are available for use, please see the relevant entry in the GGC Formulary.

Read More...

MUE 04: PPIs

Posted: Friday, December 18, 2015

Category - Medicines Update Extra

 Oral Proton Pump Inhibitors

  • Proton Pump Inhibitors (PPIs) are one of the most commonly prescribed classes of drug
  • PPIs are an effective treatment when used appropriately
  • PPIs should only be prescribed where there is a clear indication
  • PPIs are usually well tolerated
  • Recent evidence suggests that PPIs may have potentially serious adverse effects such as fractures, hypomagnesaemia, subacute cutaneous lupus erythematosus, pneumonia and Clostridium difficile infection
Read More...